Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 129

1.

Disruption of bbe02 by Insertion of a Luciferase Gene Increases Transformation Efficiency of Borrelia burgdorferi and Allows Live Imaging in Lyme Disease Susceptible C3H Mice.

Chan K, Alter L, Barthold SW, Parveen N.

PLoS One. 2015 Jun 12;10(6):e0129532. doi: 10.1371/journal.pone.0129532. eCollection 2015.

2.

Resurgence of persisting non-cultivable Borrelia burgdorferi following antibiotic treatment in mice.

Hodzic E, Imai D, Feng S, Barthold SW.

PLoS One. 2014 Jan 23;9(1):e86907. doi: 10.1371/journal.pone.0086907. eCollection 2014.

3.

MyD88- and TRIF-independent induction of type I interferon drives naive B cell accumulation but not loss of lymph node architecture in Lyme disease.

Hastey CJ, Ochoa J, Olsen KJ, Barthold SW, Baumgarth N.

Infect Immun. 2014 Apr;82(4):1548-58. doi: 10.1128/IAI.00969-13. Epub 2014 Jan 22.

4.

Correction: Persistence of Borrelia burgdorferi in Rhesus Macaques following Antibiotic Treatment of Disseminated Infection.

Embers ME, Barthold SW, Borda JT, Bowers L, Doyle L, Hodzic E, Jacobs MB, Hasenkampf NR, Martin DS, Narasimhan S, Phillippi-Falkenstein KM, Purcell JE, Ratterree MS, Philipp MT.

PLoS One. 2013 Sep 24;8(9). doi: 10.1371/annotation/f84663e3-0a2c-4243-8f97-3a58133c1b0f. eCollection 2013.

5.

Assessment of transcriptional activity of Borrelia burgdorferi and host cytokine genes during early and late infection in a mouse model.

Hodzic E, Feng S, Barthold SW.

Vector Borne Zoonotic Dis. 2013 Oct;13(10):694-711. doi: 10.1089/vbz.2012.1189. Epub 2013 Aug 9.

6.

Dynamics of connective-tissue localization during chronic Borrelia burgdorferi infection.

Imai DM, Feng S, Hodzic E, Barthold SW.

Lab Invest. 2013 Aug;93(8):900-10. doi: 10.1038/labinvest.2013.81. Epub 2013 Jun 24.

7.

Influence of arthritis-related protein (BBF01) on infectivity of Borrelia burgdorferi B31.

Imai D, Holden K, Velazquez EM, Feng S, Hodzic E, Barthold SW.

BMC Microbiol. 2013 May 7;13:100. doi: 10.1186/1471-2180-13-100.

8.

The early dissemination defect attributed to disruption of decorin-binding proteins is abolished in chronic murine Lyme borreliosis.

Imai DM, Samuels DS, Feng S, Hodzic E, Olsen K, Barthold SW.

Infect Immun. 2013 May;81(5):1663-73. doi: 10.1128/IAI.01359-12. Epub 2013 Mar 4.

9.

Comparative molecular analyses of Borrelia burgdorferi sensu stricto strains B31 and N40D10/E9 and determination of their pathogenicity.

Chan K, Awan M, Barthold SW, Parveen N.

BMC Microbiol. 2012 Jul 30;12:157. doi: 10.1186/1471-2180-12-157.

10.

Delays and diversions mark the development of B cell responses to Borrelia burgdorferi infection.

Hastey CJ, Elsner RA, Barthold SW, Baumgarth N.

J Immunol. 2012 Jun 1;188(11):5612-22. doi: 10.4049/jimmunol.1103735. Epub 2012 Apr 30.

11.

Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection.

Embers ME, Barthold SW, Borda JT, Bowers L, Doyle L, Hodzic E, Jacobs MB, Hasenkampf NR, Martin DS, Narasimhan S, Phillippi-Falkenstein KM, Purcell JE, Ratterree MS, Philipp MT.

PLoS One. 2012;7(1):e29914. doi: 10.1371/journal.pone.0029914. Epub 2012 Jan 11. Erratum in: PLoS One. 2013;8(9). doi:10.1371/annotation/f84663e3-0a2c-4243-8f97-3a58133c1b0f. PLoS One. 2012;7(4):10.1371/annotation/4cafed66-fb84-4589-a001-131d9c50aea6.

12.

Lymphoadenopathy during lyme borreliosis is caused by spirochete migration-induced specific B cell activation.

Tunev SS, Hastey CJ, Hodzic E, Feng S, Barthold SW, Baumgarth N.

PLoS Pathog. 2011 May;7(5):e1002066. doi: 10.1371/journal.ppat.1002066. Epub 2011 May 26.

13.

Lyme neuroborreliosis in 2 horses.

Imai DM, Barr BC, Daft B, Bertone JJ, Feng S, Hodzic E, Johnston JM, Olsen KJ, Barthold SW.

Vet Pathol. 2011 Nov;48(6):1151-7. doi: 10.1177/0300985811398246. Epub 2011 Feb 1.

PMID:
21285382
14.

Ineffectiveness of tigecycline against persistent Borrelia burgdorferi.

Barthold SW, Hodzic E, Imai DM, Feng S, Yang X, Luft BJ.

Antimicrob Agents Chemother. 2010 Feb;54(2):643-51. doi: 10.1128/AAC.00788-09. Epub 2009 Dec 7.

15.

Persistence of Borrelia burgdorferi following antibiotic treatment in mice.

Hodzic E, Feng S, Holden K, Freet KJ, Barthold SW.

Antimicrob Agents Chemother. 2008 May;52(5):1728-36. doi: 10.1128/AAC.01050-07. Epub 2008 Mar 3.

16.

Anti-tumor necrosis factor-alpha activation of Borrelia burgdorferi spirochetes in antibiotic-treated murine Lyme borreliosis: an unproven conclusion.

Wormser GP, Barthold SW, Shapiro ED, Dattwyler RJ, Bakken JS, Steere AC, Bockenstedt LK, Radolf JD.

J Infect Dis. 2007 Dec 15;196(12):1865-6; author reply 1866-7. doi: 10.1086/523826. No abstract available.

PMID:
18190269
17.

Infection of mice with lyme disease spirochetes constitutively producing outer surface proteins a and B.

Strother KO, Hodzic E, Barthold SW, de Silva AM.

Infect Immun. 2007 Jun;75(6):2786-94. Epub 2007 Mar 19.

18.

Coinfection with Borrelia burgdorferi sensu stricto and Borrelia garinii alters the course of murine Lyme borreliosis.

Hovius JW, Li X, Ramamoorthi N, van Dam AP, Barthold SW, van der Poll T, Speelman P, Fikrig E.

FEMS Immunol Med Microbiol. 2007 Mar;49(2):224-34.

19.

Antibody-mediated disease remission in the mouse model of lyme borreliosis.

Barthold SW, Hodzic E, Tunev S, Feng S.

Infect Immun. 2006 Aug;74(8):4817-25.

20.

Cardiac apoptosis in severe relapsing fever borreliosis.

Londoño D, Bai Y, Zückert WR, Gelderblom H, Cadavid D.

Infect Immun. 2005 Nov;73(11):7669-76.

Supplemental Content

Loading ...
Support Center